Protocol GuideExpert reviewedFact-checked March 2026

The Neuroplasticity Stack: Combining Dihexa, Lion's Mane, and Alpha-GPC

Dihexa drives synaptogenesis via HGF/c-Met. Lion's Mane stimulates NGF via hericenones. Alpha-GPC provides acetylcholine substrate for new synaptic consolidation. Three independent neuroplasticity mechanisms, one rational stack.

Evidence strength

Level 3

Case-control study

Peer-reviewed refs

1

Reading time

10 min

Key Takeaways

  • The three compounds target neuroplasticity via independent pathways — Dihexa (HGF/c-Met), Lion's Mane (NGF/BDNF), Alpha-GPC (acetylcholine) — reducing the dose of each needed versus single-compound approaches.
  • Lion's Mane is the only compound in this stack with published human RCT data for cognitive improvement — providing an evidence anchor for a stack where the other compounds have only animal/anecdotal support.
  • Dihexa's cancer concern (HGF/c-Met angiogenic activity) makes this stack inappropriate for individuals with cancer history.

Three Independent Neuroplasticity Pathways

The adult brain's ability to form new connections — neuroplasticity — depends on multiple signalling cascades operating in concert. The most important neurotrophic pathways:

BDNF/TrkB pathway: BDNF promotes synapse formation and strengthening. Exercise and sleep are primary stimulants. Semax upregulates BDNF.

NGF/TrkA pathway: Nerve Growth Factor maintains cholinergic neurons and promotes axonal growth. Lion's Mane (Hericium erinaceus) stimulates NGF production via hericenones and erinacines — small compounds that cross the blood-brain barrier and stimulate hippocampal NGF synthesis.

HGF/c-Met pathway: Hepatocyte Growth Factor via its receptor c-Met drives synaptogenesis specifically. Dihexa activates this pathway.

Acetylcholine: Not a growth factor but the neurotransmitter that functionally consolidates new synapses. Without adequate acetylcholine, newly formed synaptic connections cannot be maintained and strengthened.

The stack targets all four simultaneously — at doses potentially lower than single-compound protocols because of additive pathway effects.

Lion's Mane: The Evidence Anchor

Lion's Mane is the only compound in this stack with published human RCT data for cognitive improvement. A 2009 Japanese RCT enrolled 30 adults aged 50–80 with mild cognitive impairment and treated with 750mg/day Lion's Mane (Hericium erinaceus, standardised) for 16 weeks. []

Results: significant improvement on the Hasegawa Dementia Scale versus placebo. Cognitive improvement was dose-and-duration dependent, with decline returning after stopping supplementation. Follow-up studies have replicated improvements in attention, processing speed, and memory across multiple populations.

Mechanism: hericenones in the fruiting body and erinacines in the mycelium stimulate NGF synthesis in the hippocampus and basal forebrain — the regions most critical for declarative memory.

Building the Stack Safely

Recommended approach:

  1. Start with Lion's Mane alone for 4 weeks — establishes NGF baseline
  2. Add Alpha-GPC at week 5 — cholinergic support before synaptogenic stimulus
  3. Add Dihexa at week 6 — synaptogenesis on an established neuroplastic foundation

| Compound | Dose | Timing | |----------|------|--------| | Lion's Mane | 500–1000mg | Morning with breakfast, daily | | Alpha-GPC | 300mg | Morning with breakfast, daily | | Dihexa | 5–10mg intranasal | Morning, 5 days on/2 days off |

Cycling: Lion's Mane and Alpha-GPC can be taken continuously. Dihexa should be cycled — 4 weeks on, 2 weeks off maximum — given its poorly characterised long-term safety profile.

What to Expect

Lion's Mane effects are subtle and cumulative — users typically notice improved verbal recall and reduced cognitive fatigue over 4–8 weeks. Alpha-GPC produces more immediate effects (improved attention within 2–3 hours of dosing). Dihexa's reported effects from community experiences range from subtle enhanced clarity and word retrieval to more pronounced cognitive improvements over 2–3 week cycles.

The absence of robust human data for Dihexa means individual responses vary enormously, and the anecdotal descriptions in online communities should be interpreted cautiously.

Scientific References

  1. [1]
    Mori K, et al.. Hericium erinaceus and cognitive improvement in older adults: RCTPhytotherapy Research (2009)Oxford 1b
    PMID 18844328